| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TLN1 TLN2 | 1.44e-07 | 130 | 167 | 10 | GO:0005200 |
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 5.68e-06 | 5 | 167 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 6.60e-05 | 10 | 167 | 3 | GO:0005345 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 9.02e-05 | 11 | 167 | 3 | GO:0015217 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 9.02e-05 | 11 | 167 | 3 | GO:0015205 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 1.95e-04 | 14 | 167 | 3 | GO:0005347 | |
| GeneOntologyMolecularFunction | protein antigen binding | 2.97e-04 | 16 | 167 | 3 | GO:1990405 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 4.41e-04 | 76 | 167 | 5 | GO:0098631 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL6A2 FRAS1 TUBA3D TUBA1C TUBA3E NUP214 TUBA8 TUBA4A TUBA3C TUBA1B THBS2 HMCN2 TUBA1A AHNAK VCAN TLN1 MACF1 TLN2 | 4.91e-04 | 891 | 167 | 18 | GO:0005198 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | SIRPB1 SIRPA ADAMTS8 PFKP CDH20 ICAM5 AGER AHNAK TLN1 PAK2 MACF1 IGSF9 TLN2 NINJ1 | 5.25e-04 | 599 | 167 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 6.84e-04 | 5 | 167 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 6.84e-04 | 5 | 167 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 9.00e-04 | 23 | 167 | 3 | GO:0005346 | |
| GeneOntologyMolecularFunction | four-way junction helicase activity | 1.02e-03 | 6 | 167 | 2 | GO:0009378 | |
| GeneOntologyMolecularFunction | acetyl-CoA C-acetyltransferase activity | 1.02e-03 | 6 | 167 | 2 | GO:0003985 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 1.30e-03 | 26 | 167 | 3 | GO:0000295 | |
| GeneOntologyMolecularFunction | C-acetyltransferase activity | 1.42e-03 | 7 | 167 | 2 | GO:0016453 | |
| GeneOntologyMolecularFunction | acetyl-CoA C-acyltransferase activity | 1.42e-03 | 7 | 167 | 2 | GO:0003988 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 1.50e-03 | 59 | 167 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 1.50e-03 | 59 | 167 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 1.70e-03 | 61 | 167 | 4 | GO:0098632 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 1.79e-03 | 29 | 167 | 3 | GO:0015216 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 5.06e-06 | 5 | 166 | 3 | GO:0140021 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 2.78e-05 | 8 | 166 | 3 | GO:1990544 | |
| Domain | Alpha_tubulin | 1.05e-13 | 9 | 160 | 7 | IPR002452 | |
| Domain | Tubulin_C | 4.54e-10 | 22 | 160 | 7 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 4.54e-10 | 22 | 160 | 7 | IPR018316 | |
| Domain | Tubulin_C | 4.54e-10 | 22 | 160 | 7 | SM00865 | |
| Domain | Tub_FtsZ_C | 6.48e-10 | 23 | 160 | 7 | IPR008280 | |
| Domain | Tubulin_C | 6.48e-10 | 23 | 160 | 7 | IPR023123 | |
| Domain | TUBULIN | 6.48e-10 | 23 | 160 | 7 | PS00227 | |
| Domain | Tubulin | 6.48e-10 | 23 | 160 | 7 | IPR000217 | |
| Domain | Tubulin | 6.48e-10 | 23 | 160 | 7 | SM00864 | |
| Domain | Tubulin_CS | 6.48e-10 | 23 | 160 | 7 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 9.09e-10 | 24 | 160 | 7 | IPR003008 | |
| Domain | Tubulin | 9.09e-10 | 24 | 160 | 7 | PF00091 | |
| Domain | - | 1.26e-08 | 20 | 160 | 6 | 3.30.1330.20 | |
| Domain | - | 1.76e-08 | 21 | 160 | 6 | 1.10.287.600 | |
| Domain | - | 2.40e-08 | 22 | 160 | 6 | 3.40.50.1440 | |
| Domain | Ig_I-set | 3.89e-05 | 190 | 160 | 9 | IPR013098 | |
| Domain | I-set | 3.89e-05 | 190 | 160 | 9 | PF07679 | |
| Domain | - | 7.29e-05 | 2 | 160 | 2 | 1.20.1420.10 | |
| Domain | VBS | 7.29e-05 | 2 | 160 | 2 | PF08913 | |
| Domain | Vinculin-bd_dom | 7.29e-05 | 2 | 160 | 2 | IPR015009 | |
| Domain | Talin_cent | 7.29e-05 | 2 | 160 | 2 | IPR015224 | |
| Domain | Talin_middle | 7.29e-05 | 2 | 160 | 2 | PF09141 | |
| Domain | Cysteine_dSase | 7.29e-05 | 2 | 160 | 2 | IPR016454 | |
| Domain | Mit_uncoupling | 1.28e-04 | 12 | 160 | 3 | IPR002030 | |
| Domain | EamA | 2.10e-04 | 14 | 160 | 3 | PF00892 | |
| Domain | EamA_dom | 2.10e-04 | 14 | 160 | 3 | IPR000620 | |
| Domain | Talin-1 | 2.18e-04 | 3 | 160 | 2 | IPR015710 | |
| Domain | IG | LRFN1 SIRPB1 SIRPA HMCN2 ICAM5 AGER VCAN ROBO1 IGSF9 MERTK ALPK2 CDON | 2.82e-04 | 421 | 160 | 12 | SM00409 |
| Domain | Ig_sub | LRFN1 SIRPB1 SIRPA HMCN2 ICAM5 AGER VCAN ROBO1 IGSF9 MERTK ALPK2 CDON | 2.82e-04 | 421 | 160 | 12 | IPR003599 |
| Domain | ILWEQ_dom | 4.33e-04 | 4 | 160 | 2 | IPR002558 | |
| Domain | ILWEQ | 4.33e-04 | 4 | 160 | 2 | SM00307 | |
| Domain | FERM_f0 | 4.33e-04 | 4 | 160 | 2 | PF16511 | |
| Domain | ILWEQ | 4.33e-04 | 4 | 160 | 2 | PD011820 | |
| Domain | - | 4.33e-04 | 4 | 160 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 4.33e-04 | 4 | 160 | 2 | PF01608 | |
| Domain | I_LWEQ | 4.33e-04 | 4 | 160 | 2 | PS50945 | |
| Domain | FERM_f0 | 4.33e-04 | 4 | 160 | 2 | IPR032425 | |
| Domain | NUT | 7.17e-04 | 5 | 160 | 2 | IPR024310 | |
| Domain | NUT_N | 7.17e-04 | 5 | 160 | 2 | IPR024309 | |
| Domain | AA_TRANSFER_CLASS_5 | 7.17e-04 | 5 | 160 | 2 | PS00595 | |
| Domain | NUT | 7.17e-04 | 5 | 160 | 2 | PF12881 | |
| Domain | Thiolase_AS | 7.17e-04 | 5 | 160 | 2 | IPR020610 | |
| Domain | IGc2 | 9.66e-04 | 235 | 160 | 8 | SM00408 | |
| Domain | Ig_sub2 | 9.66e-04 | 235 | 160 | 8 | IPR003598 | |
| Domain | Thiolase_C | 1.07e-03 | 6 | 160 | 2 | PF02803 | |
| Domain | THIOLASE_2 | 1.07e-03 | 6 | 160 | 2 | PS00737 | |
| Domain | THIOLASE_1 | 1.07e-03 | 6 | 160 | 2 | PS00098 | |
| Domain | THIOLASE_3 | 1.07e-03 | 6 | 160 | 2 | PS00099 | |
| Domain | Thiolase_N | 1.07e-03 | 6 | 160 | 2 | IPR020616 | |
| Domain | Thiolase_C | 1.07e-03 | 6 | 160 | 2 | IPR020617 | |
| Domain | Thiolase_CS | 1.07e-03 | 6 | 160 | 2 | IPR020613 | |
| Domain | Thiolase | 1.07e-03 | 6 | 160 | 2 | IPR002155 | |
| Domain | Aminotrans_V_dom | 1.07e-03 | 6 | 160 | 2 | IPR000192 | |
| Domain | Thiolase_N | 1.07e-03 | 6 | 160 | 2 | PF00108 | |
| Domain | Aminotran_5 | 1.07e-03 | 6 | 160 | 2 | PF00266 | |
| Domain | IG_LIKE | LRFN1 SIRPB1 SIRPA HMCN2 ICAM5 AGER VCAN ROBO1 IGSF9 MERTK ALPK2 CDON | 1.09e-03 | 491 | 160 | 12 | PS50835 |
| Domain | Ig-like_dom | LRFN1 SIRPB1 SIRPA HMCN2 ICAM5 AGER VCAN ROBO1 IGSF9 MERTK ALPK2 CDON | 1.34e-03 | 503 | 160 | 12 | IPR007110 |
| Domain | - | 1.49e-03 | 7 | 160 | 2 | 3.30.390.30 | |
| Domain | Vinculin/catenin | 1.49e-03 | 7 | 160 | 2 | IPR006077 | |
| Domain | Aden_trnslctor | 1.73e-03 | 28 | 160 | 3 | IPR002113 | |
| Domain | Pyr_nucl-diS_OxRdtase_dimer | 1.97e-03 | 8 | 160 | 2 | IPR004099 | |
| Domain | FAD/NAD-linked_Rdtase_dimer | 1.97e-03 | 8 | 160 | 2 | IPR016156 | |
| Domain | Calx_beta | 1.97e-03 | 8 | 160 | 2 | SM00237 | |
| Domain | - | 2.34e-03 | 333 | 160 | 9 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.44e-03 | 335 | 160 | 9 | IPR015943 | |
| Domain | Calx_beta | 2.52e-03 | 9 | 160 | 2 | IPR003644 | |
| Domain | Calx-beta | 2.52e-03 | 9 | 160 | 2 | PF03160 | |
| Domain | Mit_carrier | 2.55e-03 | 32 | 160 | 3 | IPR002067 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 4.04e-13 | 17 | 117 | 8 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 7.21e-13 | 18 | 117 | 8 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.24e-12 | 19 | 117 | 8 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.24e-12 | 19 | 117 | 8 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 2.05e-12 | 20 | 117 | 8 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 2.05e-12 | 20 | 117 | 8 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.29e-12 | 21 | 117 | 8 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.29e-12 | 21 | 117 | 8 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 5.13e-12 | 22 | 117 | 8 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 7.81e-12 | 23 | 117 | 8 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 7.81e-12 | 23 | 117 | 8 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 7.81e-12 | 23 | 117 | 8 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.16e-11 | 24 | 117 | 8 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.16e-11 | 24 | 117 | 8 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.70e-11 | 25 | 117 | 8 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.70e-11 | 25 | 117 | 8 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 2.44e-11 | 26 | 117 | 8 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.44e-11 | 26 | 117 | 8 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 4.78e-11 | 28 | 117 | 8 | M47898 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DNAH6 | 6.09e-11 | 43 | 117 | 9 | M47669 |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 6.56e-11 | 29 | 117 | 8 | M27948 | |
| Pathway | REACTOME_AGGREPHAGY | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A UBE2V1 | 7.60e-11 | 44 | 117 | 9 | M29830 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DNAH6 | 9.44e-11 | 45 | 117 | 9 | M47670 |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.57e-10 | 32 | 117 | 8 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.57e-10 | 32 | 117 | 8 | M27491 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 2.06e-10 | 33 | 117 | 8 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 2.06e-10 | 33 | 117 | 8 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 3.45e-10 | 35 | 117 | 8 | M47774 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | TUBA3D TUBA1C TUBA3E TUBA8 FANCM TUBA4A TUBA3C TUBA1B DUS2 TUBA1A | 6.33e-10 | 76 | 117 | 10 | M48037 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 7.02e-10 | 38 | 117 | 8 | M14981 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 2.01e-09 | 43 | 117 | 8 | M47773 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.44e-09 | 44 | 117 | 8 | M27934 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.30e-09 | 17 | 117 | 6 | MM14731 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 3.55e-09 | 46 | 117 | 8 | M27828 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 6.00e-09 | 49 | 117 | 8 | M891 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 8.36e-09 | 51 | 117 | 8 | M26972 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.15e-08 | 53 | 117 | 8 | M27651 | |
| Pathway | REACTOME_AGGREPHAGY | 1.55e-08 | 36 | 117 | 7 | MM15669 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.56e-08 | 55 | 117 | 8 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.80e-08 | 56 | 117 | 8 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.08e-08 | 57 | 117 | 8 | M27251 | |
| Pathway | REACTOME_KINESINS | 3.61e-08 | 61 | 117 | 8 | M977 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | TUBA3D TUBA1C TUBA3E NUP214 TUBA8 FANCM TUBA4A TUBA3C TUBA1B DUS2 TUBA1A | 4.84e-08 | 151 | 117 | 11 | M550 |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A UBE2V1 | 5.51e-08 | 90 | 117 | 9 | M29841 |
| Pathway | KEGG_GAP_JUNCTION | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A GUCY1A1 | 5.51e-08 | 90 | 117 | 9 | M4013 |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 6.80e-08 | 66 | 117 | 8 | MM17074 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 7.38e-08 | 27 | 117 | 6 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 7.38e-08 | 27 | 117 | 6 | MM15674 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.17e-07 | 29 | 117 | 6 | MM15219 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.22e-07 | 71 | 117 | 8 | M39690 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 1.36e-07 | 72 | 117 | 8 | M26954 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.08e-07 | 76 | 117 | 8 | M27215 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.18e-07 | 32 | 117 | 6 | MM14730 | |
| Pathway | WP_ALZHEIMERS_DISEASE | SLC25A4 SLC25A5 SLC25A6 TUBA3D TUBA1C ATG2B TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A AGER | 2.49e-07 | 261 | 117 | 13 | M42565 |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 2.82e-07 | 79 | 117 | 8 | M27743 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 5.07e-07 | 20 | 117 | 5 | MM1383 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 5.41e-07 | 37 | 117 | 6 | MM15102 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.09e-06 | 94 | 117 | 8 | M2843 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.09e-06 | 94 | 117 | 8 | MM14515 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.18e-06 | 95 | 117 | 8 | M6729 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 1.49e-06 | 98 | 117 | 8 | M776 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.57e-06 | 44 | 117 | 6 | MM14606 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.74e-06 | 100 | 117 | 8 | M27650 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 2.03e-06 | 102 | 117 | 8 | M27648 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 2.12e-06 | 12 | 117 | 4 | M27728 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | TUBA3D TUBA1C TUBA3E NUP214 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 2.15e-06 | 138 | 117 | 9 | M29805 |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 2.35e-06 | 73 | 117 | 7 | MM15672 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A MRTFA | 2.42e-06 | 140 | 117 | 9 | M27550 |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.65e-06 | 48 | 117 | 6 | MM15353 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | SLC25A4 SLC25A5 SLC25A6 TUBA3D TUBA1C ATG2B TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A AGER | 3.04e-06 | 326 | 117 | 13 | M39379 |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 4.28e-06 | 52 | 117 | 6 | MM14949 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 5.36e-06 | 54 | 117 | 6 | M27482 | |
| Pathway | REACTOME_AUTOPHAGY | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A UBE2V1 | 6.54e-06 | 158 | 117 | 9 | M27935 |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 7.30e-06 | 121 | 117 | 8 | M872 | |
| Pathway | REACTOME_KINESINS | 7.38e-06 | 57 | 117 | 6 | MM15714 | |
| Pathway | REACTOME_HCMV_INFECTION | TUBA3D TUBA1C TUBA3E NUP214 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 8.01e-06 | 162 | 117 | 9 | M29804 |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 9.84e-06 | 126 | 117 | 8 | M705 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.04e-05 | 127 | 117 | 8 | M27181 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 1.55e-05 | 134 | 117 | 8 | M27751 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | TUBA3D TUBA1C TUBA3E NUP214 TUBA8 FANCM TUBA4A TUBA3C TUBA1B DUS2 TUBA1A | 1.66e-05 | 273 | 117 | 11 | M983 |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.91e-05 | 138 | 117 | 8 | MM15635 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.07e-05 | 68 | 117 | 6 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.07e-05 | 68 | 117 | 6 | MM14968 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 2.24e-05 | 141 | 117 | 8 | MM15266 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A ANAPC1 | 2.99e-05 | 191 | 117 | 9 | M29614 |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 3.11e-05 | 73 | 117 | 6 | MM15491 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 3.49e-05 | 150 | 117 | 8 | M27440 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 4.23e-05 | 113 | 117 | 7 | M27471 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 4.62e-05 | 156 | 117 | 8 | M27097 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 6.41e-05 | 10 | 117 | 3 | M47694 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 6.88e-05 | 52 | 117 | 5 | MM15211 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL6A2 ZSWIM8 TUBA3D TUBA1C TUBA3E ADGRV1 TUBA8 PABPC1 TUBA4A TUBA3C TUBA1B TUBA1A TLN1 PAK2 ROBO1 | 8.08e-05 | 575 | 117 | 15 | M29853 |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 8.48e-05 | 170 | 117 | 8 | M941 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 8.76e-05 | 11 | 117 | 3 | MM15471 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 9.83e-05 | 129 | 117 | 7 | MM14894 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.01e-04 | 90 | 117 | 6 | MM14979 | |
| Pathway | REACTOME_MACROAUTOPHAGY | 1.03e-04 | 130 | 117 | 7 | MM14627 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.43e-04 | 137 | 117 | 7 | MM15182 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.50e-04 | 13 | 117 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.50e-04 | 13 | 117 | 3 | M47751 | |
| Pubmed | 2.47e-18 | 9 | 170 | 8 | 21167302 | ||
| Pubmed | 1.99e-14 | 19 | 170 | 8 | 15698476 | ||
| Pubmed | 1.99e-14 | 19 | 170 | 8 | 15691386 | ||
| Pubmed | 8.33e-14 | 22 | 170 | 8 | 28117675 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CRYBG2 FRAS1 LRFN1 RAPGEF6 HIVEP2 CDC42BPA IMPDH1 EP400 NSD2 FYCO1 NUP214 TEP1 ZZEF1 BIRC6 LYST WDR59 ELAC2 SIL1 C2CD2L FOCAD SCAF1 AHNAK CASKIN1 ZNF408 TLN1 TP53I13 TLN2 HMGXB3 AHNAK2 | 1.51e-13 | 1105 | 170 | 29 | 35748872 |
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 3.47e-13 | 8 | 170 | 6 | 16148047 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 9.44e-12 | 22 | 170 | 7 | 23826228 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 1.13e-11 | 12 | 170 | 6 | 15331610 | |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | SLC25A4 SLC25A5 SLC25A6 PFKP PABPC1 TUBA4A TUBA1B TUBA1A AHNAK MERTK | 1.21e-11 | 84 | 170 | 10 | 25670202 |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | SLC25A4 SLC25A5 SLC25A6 TUBA1C TUBA3E TUBA8 PABPC1 TUBA4A TUBA3C TUBA1B TUBA1A AIFM1 AHCY GPC4 TPI1 | 1.51e-11 | 288 | 170 | 15 | 31501420 |
| Pubmed | 1.57e-11 | 6 | 170 | 5 | 3785200 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 1.57e-11 | 6 | 170 | 5 | 7651436 | |
| Pubmed | 1.57e-11 | 6 | 170 | 5 | 16327313 | ||
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 2.08e-11 | 13 | 170 | 6 | 10908577 | |
| Pubmed | 3.63e-11 | 14 | 170 | 6 | 12486001 | ||
| Pubmed | SLC25A4 SLC25A5 SLC25A6 TUBA1C TUBA3E TUBA8 TUBA4A TUBA1B TUBA1A TPI1 | 3.79e-11 | 94 | 170 | 10 | 36584595 | |
| Pubmed | ZSWIM8 FMR1 EP400 TCOF1 NSD2 TCP11L1 FAT3 BPIFB1 RNF213 KPNA6 SIRPB1 RSRC2 TEP1 SOWAHC WDR37 ZZEF1 C2CD2L SCAF1 HMCN2 GSE1 ANAPC1 ARID2 PANK4 TNRC6A MACF1 MBD2 | 4.34e-11 | 1116 | 170 | 26 | 31753913 | |
| Pubmed | 5.48e-11 | 7 | 170 | 5 | 11146551 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EP400 TUBA1C RNF213 PRPF6 NUP214 PFKP TUBA4A ELAC2 TUBA1B ANAPC1 ARID2 AHNAK TLN1 BOD1L1 AHNAK2 | 1.11e-10 | 332 | 170 | 15 | 32786267 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RAPGEF6 EP400 TCOF1 ATG2B PTPN23 SPAG9 NUP214 PFKP PABPC1 UBE2O GSE1 ARID2 AHNAK TLN1 AHCY PAK2 MACF1 BOD1L1 ALDH3A2 OGA WDR44 AHNAK2 TPI1 | 2.20e-10 | 934 | 170 | 23 | 33916271 |
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 3.26e-10 | 9 | 170 | 5 | 11953448 | |
| Pubmed | SLC25A4 SLC25A5 SLC25A6 TUBA1C PRPF6 PFKP PABPC1 TUBA4A TUBA1B ATP6V1H TUBA1A AHNAK CASKIN1 TLN1 RECQL5 NEMF AHCY GPC4 ALDH3A2 METTL17 TPI1 | 4.88e-10 | 803 | 170 | 21 | 36517590 | |
| Pubmed | 5.51e-10 | 4 | 170 | 4 | 18400243 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | IMPDH1 ACAT2 TUBA1C PTPN23 KPNA6 SPAG9 SCLY PFKP ZZEF1 BIRC6 PABPC1 TUBA4A ELAC2 UFM1 TXNRD1 UBE2O ATP6V1H TUBA1A UBE2V1 AHNAK TLN1 PANK4 AHCY PAK2 MACF1 OGA WDR44 AHNAK2 | 5.63e-10 | 1455 | 170 | 28 | 22863883 |
| Pubmed | 8.73e-10 | 22 | 170 | 6 | 15103018 | ||
| Pubmed | NES SLC25A4 SLC25A5 SLC25A6 TCP11L1 TUBA1C RGPD1 RNF213 TUBA3E KPNA6 PFKP PABPC1 TUBA4A TUBA3C TUBA1A AHNAK TLN1 AHCY MACF1 C4A TPI1 | 1.19e-09 | 844 | 170 | 21 | 25963833 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DDX12P SLC25A4 SLC25A5 SLC25A6 TUBA1C RGPD1 KPNA6 PRPF6 PFKP BIRC6 PABPC1 TUBA4A TUBA3C ELAC2 TUBA1B ATP6V1H MAGED4 TUBA1A ANAPC1 AIFM1 PANK4 AHCY ALDH3A2 OGA TPI1 | 2.73e-09 | 1257 | 170 | 25 | 37317656 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ACAA1 SLC25A5 SLC25A6 TUBA3D TUBA1C GPRIN3 FYCO1 PFKP ZZEF1 PABPC1 TXNRD1 UBE2V1 AIFM1 AHNAK TLN1 AHCY MACF1 RBM46 AHNAK2 TPI1 | 3.24e-09 | 807 | 170 | 20 | 30575818 |
| Pubmed | NES ZSWIM8 FMR1 TCOF1 NSD2 TUBA1C SPAG9 PRPF6 NUP214 PFKP BIRC6 PABPC1 UBE2O ANAPC1 AHNAK TLN1 MACF1 RRP7A | 4.08e-09 | 653 | 170 | 18 | 22586326 | |
| Pubmed | TCOF1 TUBA3D TUBA1C TUBA3E PFKP TUBA8 PABPC1 TUBA4A TUBA3C TUBA1B TUBA1A | 8.81e-09 | 212 | 170 | 11 | 23463506 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EP400 SLC25A4 SLC25A5 NSD2 TUBA1C NUTM2A PRPF6 NUP214 FANCM PABPC1 TUBA4A TUBA1B BRCA2 NUTM2B ARID2 AHNAK ZNF451 RECQL5 BOD1L1 HNRNPCL2 NPAT | 1.01e-08 | 954 | 170 | 21 | 36373674 |
| Pubmed | RAPGEF6 EP400 SLC25A5 TCOF1 ATG2B PTPN23 SPAG9 UBE2O ANAPC1 ICAM5 ARID2 AHNAK TLN1 PAK2 BOD1L1 WDR44 | 1.44e-08 | 549 | 170 | 16 | 38280479 | |
| Pubmed | 1.55e-08 | 17 | 170 | 5 | 17360745 | ||
| Pubmed | PTPN23 SPAG9 ADGRV1 BIRC6 C2CD2L TLN1 SIK2 MACF1 TLN2 OGA MRTFA | 1.63e-08 | 225 | 170 | 11 | 12168954 | |
| Pubmed | 1.91e-08 | 7 | 170 | 4 | 36681692 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | NES ABHD10 PTPN23 PRPF6 NUP214 WDR37 TUBA1B SACS TUBA1A AHNAK VCAN GPC4 MACF1 TLN2 BOD1L1 | 2.70e-08 | 498 | 170 | 15 | 36634849 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SLC25A4 SLC25A5 TCOF1 SLC25A6 TUBA1C PTPN23 KPNA6 PRPF6 PFKP BIRC6 PABPC1 TUBA4A ELAC2 TXNRD1 TUBA1B UBE2O TUBA1A AIFM1 AHNAK TLN1 NEMF AHCY MACF1 AHNAK2 TPI1 | 2.81e-08 | 1415 | 170 | 25 | 28515276 |
| Pubmed | SLC25A4 SLC25A5 SLC25A6 TUBA3D TUBA1C TUBA3E TUBA8 PABPC1 TUBA3C TUBA1B TUBA1A | 3.03e-08 | 239 | 170 | 11 | 23246001 | |
| Pubmed | SLC25A4 SLC25A5 SLC25A6 RNF213 TUBA8 ZZEF1 PABPC1 TUBA1B TUBA1A DNAH6 | 3.20e-08 | 187 | 170 | 10 | 26460568 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SLC25A4 TCP11L1 RGPD1 BPIFB1 TUBA3E KPNA6 SPAG9 PRPF6 NUP214 PABPC1 TUBA1B CEP120 ANAPC1 AIFM1 ARID2 AHNAK ZNF451 TLN1 AHCY TLN2 ALDH3A2 BEGAIN | 5.70e-08 | 1155 | 170 | 22 | 20360068 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | NES RAPGEF6 TCOF1 ATG2B NUP214 TUBA4A TUBA1A AHNAK TLN1 ROBO1 AHNAK2 | 6.11e-08 | 256 | 170 | 11 | 33397691 |
| Pubmed | FMR1 CDC42BPA IMPDH1 EP400 SLC25A5 TCOF1 NUTM2A PRPF6 RSRC2 PABPC1 UFM1 DUS2 SCAF1 AIFM1 AHNAK ZNF451 TLN1 NEMF AHCY TNRC6A RRP7A MBD2 METTL17 TPI1 | 6.52e-08 | 1371 | 170 | 24 | 36244648 | |
| Pubmed | 6.81e-08 | 9 | 170 | 4 | 19103752 | ||
| Pubmed | CDC42BPA SLC25A5 TCOF1 ATG2B PTPN23 NUP214 PABPC1 ATP6V1H AIFM1 AHNAK TLN1 AHCY PAK2 ROBO1 MACF1 BOD1L1 ALDH3A2 | 8.27e-08 | 708 | 170 | 17 | 39231216 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | EP400 TCOF1 TUBA1C RGPD1 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A AIFM1 AHNAK | 1.09e-07 | 271 | 170 | 11 | 32433965 |
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | 1.12e-07 | 116 | 170 | 8 | 22810585 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 12450408 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 1.15e-07 | 3 | 170 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 1.15e-07 | 3 | 170 | 3 | 2829183 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 11163133 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 1.15e-07 | 3 | 170 | 3 | 9722999 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FMR1 SLC25A5 TCOF1 NSD2 TUBA1C KIAA0586 KPNA6 PRPF6 NUP214 PABPC1 TUBA1B SCAF1 UBE2O ATP6V1H ANAPC1 AIFM1 TLN1 NEMF AHCY RRP7A TLN2 BOD1L1 ALDH3A2 TPI1 | 1.33e-07 | 1425 | 170 | 24 | 30948266 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SLC25A5 TOPAZ1 RNF213 SPAG9 PFKP ZZEF1 BIRC6 FOCAD SCAF1 CDH20 GSE1 TUBA1A AIFM1 AHNAK ZNF408 TLN1 BOD1L1 | 1.43e-07 | 736 | 170 | 17 | 29676528 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES EP400 SLC25A5 TCOF1 SLC25A6 TUBA1C PRPF6 NUP214 PFKP PABPC1 TUBA4A TUBA1B SCAF1 SACS AIFM1 AHNAK TLN1 AHCY MACF1 TPI1 | 1.61e-07 | 1024 | 170 | 20 | 24711643 |
| Pubmed | RAPGEF6 ATG2B RGPD1 NUP214 BIRC6 GSE1 BRCA2 ZNF532 ANAPC1 AHNAK TNRC6A MRTFA NPAT | 1.64e-07 | 418 | 170 | 13 | 34709266 | |
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 1.77e-07 | 11 | 170 | 4 | 20405035 | |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 2.00e-07 | 125 | 170 | 8 | 36030824 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES EP400 SLC25A5 ACAT2 TBPL1 PTPN23 PRPF6 NUP214 PFKP BIRC6 PABPC1 TUBA4A WDR59 ELAC2 AIFM1 AHNAK TLN1 RECQL5 AHCY MACF1 DDX60L AHNAK2 TPI1 | 2.12e-07 | 1353 | 170 | 23 | 29467282 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZSWIM8 EP400 TCOF1 KPNA6 ZCCHC2 GSE1 BRCA2 TUBA1A ANAPC1 ARID2 ZNF451 RECQL5 TNRC6A MACF1 ALDH3A2 | 2.31e-07 | 588 | 170 | 15 | 38580884 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | NES TCOF1 ACAT2 TCP11L1 TUBA1C KPNA6 SPAG9 PRPF6 PFKP PABPC1 TUBA4A TUBA1B UBE2O AHNAK TLN1 NEMF PANK4 AHCY MACF1 OGA TPI1 | 2.32e-07 | 1149 | 170 | 21 | 35446349 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | TCP11L1 TUBA1C SOWAHC TUBA4A TUBA1B ATP6V1H AIFM1 TLN1 MACF1 OGA | 2.70e-07 | 235 | 170 | 10 | 28378594 |
| Pubmed | FRAS1 CDC42BPA TCOF1 SLC25A6 FLVCR1 TUBA1C ACOT1 PRPF6 PFKP NFS1 ELAC2 UBE2O SACS AIFM1 ZNF451 TLN1 PANK4 SIK2 ROBO1 MACF1 ALDH3A2 OGA TPI1 NPAT | 2.88e-07 | 1487 | 170 | 24 | 33957083 | |
| Pubmed | NES LRFN1 FMR1 TCOF1 RGPD1 FYCO1 SIRPB1 SIRPA ARMCX4 PABPC1 UBE2O UBE2V1 ANAPC1 ICAM5 CASKIN1 PAK2 MACF1 TLN2 BEGAIN | 2.89e-07 | 963 | 170 | 19 | 28671696 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | EP400 TUBA1C SPAG9 TUBA3C BRCA2 AHNAK ZNF451 TLN1 SYNGR2 AHCY PAK2 AHNAK2 TPI1 | 3.26e-07 | 444 | 170 | 13 | 34795231 |
| Pubmed | SLC25A5 TCOF1 SLC25A6 ACAT2 TUBA1C NUTM2A TUBA3E SPAG9 TUBA4A TUBA3C TUBA1B ATP6V1H NUTM2B TUBA1A AIFM1 TLN1 AHCY TPI1 | 3.48e-07 | 878 | 170 | 18 | 37223481 | |
| Pubmed | ZSWIM8 HIVEP2 TCOF1 KPNA6 ACOT1 ADAMTS8 ARMCX4 LRP1B WDR59 FOCAD TUBA1B UBE2O ZNF532 SACS ZNF451 NEMF AHCY PAK2 ROBO1 MACF1 TLN2 MERTK | 3.54e-07 | 1285 | 170 | 22 | 35914814 | |
| Pubmed | TCOF1 SLC25A6 PTPN23 KPNA6 ACOT1 NUP214 PFKP BIRC6 PABPC1 TUBA4A ELAC2 TUBA1B ATP6V1H AIFM1 AHNAK SYNGR2 NEMF AHCY ROBO1 MACF1 BOD1L1 ALDH3A2 | 4.13e-07 | 1297 | 170 | 22 | 33545068 | |
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 9056918 | ||
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 33396658 | ||
| Pubmed | Emergence of primate genes by retrotransposon-mediated sequence transduction. | 4.57e-07 | 4 | 170 | 3 | 17101974 | |
| Pubmed | LRFN1 FMR1 SLC25A5 SLC25A6 KPNA6 NUP214 PABPC1 TUBA1B TUBA1A AHCY RRP7A ALDH3A2 TPI1 | 5.22e-07 | 463 | 170 | 13 | 34901782 | |
| Pubmed | NES FMR1 SLC25A4 SLC25A5 TUBA1C PFKP WDR37 PABPC1 TUBA4A UBE2O ATP6V1H SACS TUBA1A ICAM5 CASKIN1 VCAN TLN1 MACF1 TLN2 C4A DNAH6 HNRNPCL2 TPI1 | 5.61e-07 | 1431 | 170 | 23 | 37142655 | |
| Pubmed | CDC42BPA SLC25A5 TCOF1 PTPN23 TUBA3E TUBA8 TUBA1B ANTXR2 ATP4A | 7.41e-07 | 202 | 170 | 9 | 24639526 | |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 7.41e-07 | 202 | 170 | 9 | 33601422 | |
| Pubmed | FMR1 SLC25A5 TCOF1 SLC25A6 TUBA1C PRPF6 FANCM PABPC1 TUBA4A BRCA2 AHNAK TLN1 RECQL5 AHCY TPI1 | 8.45e-07 | 652 | 170 | 15 | 31180492 | |
| Pubmed | 8.72e-07 | 206 | 170 | 9 | 22174317 | ||
| Pubmed | FMR1 SLC25A5 TCOF1 SLC25A6 TUBA1C PRPF6 NUP214 PFKP NFS1 PABPC1 TUBA1B GSE1 AIFM1 TNRC6A MBD2 | 8.95e-07 | 655 | 170 | 15 | 35819319 | |
| Pubmed | HIVEP2 CDC42BPA PTPN23 KPNA6 NUP214 ARID2 ZNF451 TNRC6A PAK2 ROBO1 MACF1 C4A WDR44 | 8.98e-07 | 486 | 170 | 13 | 20936779 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | FMR1 SLC25A4 SLC25A5 SLC25A6 TUBA1C PFKP PABPC1 TUBA4A TUBA1A AIFM1 ARID2 NEMF ALDH3A2 | 8.98e-07 | 486 | 170 | 13 | 30940648 |
| Pubmed | SLC25A5 TCOF1 SLC25A6 TUBA1C PRPF6 PABPC1 TUBA4A TUBA1B TUBA1A AHNAK TLN1 AHCY MACF1 | 9.40e-07 | 488 | 170 | 13 | 31324722 | |
| Pubmed | 9.73e-07 | 67 | 170 | 6 | 30669930 | ||
| Pubmed | RAPGEF6 SLC25A5 KIAA0586 ATG2B RGPD1 UBE2O TNRC6A ROBO1 MACF1 | 9.83e-07 | 209 | 170 | 9 | 36779422 | |
| Pubmed | TCOF1 TUBA1C SPAG9 PRPF6 NUP214 PFKP PABPC1 TUBA4A AHNAK TLN1 AHCY TNRC6A TPI1 | 1.08e-06 | 494 | 170 | 13 | 26831064 | |
| Pubmed | ZSWIM8 is a myogenic protein that partly prevents C2C12 differentiation. | 1.14e-06 | 5 | 170 | 3 | 34686700 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | FMR1 SLC25A4 SLC25A5 SLC25A6 ABHD10 ATG2B RNF213 ACOT1 SPAG9 ARMCX4 NFS1 ZZEF1 BIRC6 TRMT2B ELAC2 C2CD2L AIFM1 ARID2 PANK4 ALDH3A2 METTL17 WDR44 AHNAK2 | 1.20e-06 | 1496 | 170 | 23 | 32877691 |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | SLC25A4 SLC25A5 TCOF1 SLC25A6 TUBA1C PRPF6 TUBA4A AHNAK TLN1 AHCY AHNAK2 TPI1 | 1.27e-06 | 422 | 170 | 12 | 27342126 |
| Pubmed | EP400 NUP214 PFKP TUBA4A TUBA1A ANAPC1 GPC4 MACF1 BOD1L1 MBD2 | 1.42e-06 | 282 | 170 | 10 | 23667531 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NES CDC42BPA EP400 SLC25A4 SLC25A5 TCOF1 SLC25A6 NSD2 ABHD10 PRPF6 RSRC2 ZNF532 SACS TUBA1A ARID2 VCAN NEMF GPC4 MACF1 | 1.64e-06 | 1082 | 170 | 19 | 38697112 |
| Pubmed | 2.06e-06 | 76 | 170 | 6 | 27542412 | ||
| Pubmed | 2.27e-06 | 6 | 170 | 3 | 10620603 | ||
| Pubmed | 2.27e-06 | 6 | 170 | 3 | 18613978 | ||
| Pubmed | 2.27e-06 | 6 | 170 | 3 | 12090300 | ||
| Pubmed | 2.27e-06 | 6 | 170 | 3 | 10840040 | ||
| Pubmed | CDC42BPA EP400 NSD2 ADGRV1 WDR37 ZZEF1 UBE2O ZNF532 CASKIN1 TNRC6A IGSF9 HMGXB3 OGA | 2.29e-06 | 529 | 170 | 13 | 14621295 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | SLC25A4 SLC25A5 SIRPB1 SIRPA PFKP TUBA8 PABPC1 TUBA1B BRCA2 TUBA1A ICAM5 AHCY ATP4A HNRNPCL2 | 2.51e-06 | 621 | 170 | 14 | 22794259 |
| Pubmed | FMR1 CDC42BPA ACAA1 IMPDH1 SLC25A5 TCOF1 SLC25A6 PRPF6 NUP214 RSRC2 PFKP PABPC1 TUBA4A ELAC2 ATP6V1H TUBA1A AIFM1 TLN1 NEMF AHCY | 3.37e-06 | 1247 | 170 | 20 | 27684187 | |
| Pubmed | Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology. | 3.40e-06 | 243 | 170 | 9 | 36964488 | |
| Pubmed | FMR1 CDC42BPA SLC25A5 ATG2B RGPD1 NFS1 BIRC6 LRP1B TUBA4A UFM1 C2CD2L UBE2O UBE2V1 CASKIN1 TNRC6A MACF1 TLN2 BEGAIN TPI1 | 3.44e-06 | 1139 | 170 | 19 | 36417873 | |
| Pubmed | NES EP400 RNF213 NUP214 RSRC2 BIRC6 WDR59 C2CD2L UBE2O ANAPC1 ZNF451 TNRC6A ROBO1 BOD1L1 YIPF3 | 3.54e-06 | 733 | 170 | 15 | 34672954 | |
| Interaction | TCP11L2 interactions | 2.39e-10 | 21 | 166 | 7 | int:TCP11L2 | |
| Interaction | TOP3B interactions | CRYBG2 FRAS1 LRFN1 RAPGEF6 HIVEP2 FMR1 CDC42BPA IMPDH1 EP400 NSD2 FYCO1 NUP214 PFKP TEP1 ZZEF1 BIRC6 LYST PABPC1 WDR59 ELAC2 SIL1 C2CD2L FOCAD SCAF1 AHNAK CASKIN1 ZNF408 TLN1 RECQL5 GPC4 TP53I13 TLN2 HMGXB3 OGA AHNAK2 | 9.31e-09 | 1470 | 166 | 35 | int:TOP3B |
| Interaction | OSTM1 interactions | SLC25A4 SLC25A5 SLC25A6 FLVCR1 TUBA1C RNF213 TUBA4A TUBA1A METTL17 | 1.97e-08 | 80 | 166 | 9 | int:OSTM1 |
| Interaction | YAP1 interactions | RAPGEF6 SLC25A4 SLC25A5 TCOF1 SLC25A6 TUBA1C TUBA3E SPAG9 PFKP TUBA8 PABPC1 TUBA4A TUBA3C UFM1 TUBA1B UBE2O TUBA1A ANAPC1 AIFM1 ICAM5 ARID2 AHNAK TLN1 RECQL5 AHCY GPC4 PAK2 BOD1L1 TPI1 | 2.23e-08 | 1095 | 166 | 29 | int:YAP1 |
| Interaction | C2CD4B interactions | 6.72e-08 | 44 | 166 | 7 | int:C2CD4B | |
| Interaction | SKI interactions | SLC25A4 SLC25A5 SLC25A6 PFKP PABPC1 TUBA4A TUBA1B TUBA1A GLI2 AHNAK MERTK | 9.15e-08 | 160 | 166 | 11 | int:SKI |
| Interaction | TFCP2 interactions | ACAA1 SLC25A4 SLC25A5 SLC25A6 TUBA1C TUBA3E TUBA8 PABPC1 TUBA4A TUBA3C TUBA1B TUBA1A AIFM1 AHCY GPC4 PHF21B TPI1 | 1.27e-07 | 436 | 166 | 17 | int:TFCP2 |
| Interaction | GRM7 interactions | 3.78e-07 | 19 | 166 | 5 | int:GRM7 | |
| Interaction | SUMO2 interactions | EP400 TUBA1C RNF213 PRPF6 NUP214 PFKP TUBA4A ELAC2 TUBA1B ANAPC1 GLI2 ARID2 AHNAK ZNF451 TLN1 BOD1L1 MERTK AHNAK2 TPI1 | 4.40e-07 | 591 | 166 | 19 | int:SUMO2 |
| Interaction | NAA40 interactions | RAPGEF6 EP400 TCOF1 ATG2B PTPN23 SPAG9 NUP214 PFKP PABPC1 UBE2O GSE1 ARID2 AHNAK TLN1 AHCY PAK2 MACF1 BOD1L1 ALDH3A2 OGA HNRNPCL2 WDR44 AHNAK2 TPI1 | 1.64e-06 | 978 | 166 | 24 | int:NAA40 |
| Interaction | ADAMTS4 interactions | 2.13e-06 | 72 | 166 | 7 | int:ADAMTS4 | |
| Interaction | PXN interactions | SLC25A5 SLC25A6 PTPN23 TUBA8 BIRC6 PABPC1 TUBA3C TUBA1B TLN1 AHCY TNRC6A PAK2 MACF1 | 4.18e-06 | 334 | 166 | 13 | int:PXN |
| Interaction | CAPSL interactions | 5.65e-06 | 15 | 166 | 4 | int:CAPSL | |
| Interaction | MCM2 interactions | EP400 SLC25A4 SLC25A5 SLC25A6 TCP11L1 TUBA1C ATG2B RGPD1 RNF213 TUBA3E KPNA6 SPAG9 PFKP PABPC1 TUBA4A TUBA3C UBE2O TUBA1A AHNAK TLN1 AHCY MACF1 C4A TPI1 | 9.04e-06 | 1081 | 166 | 24 | int:MCM2 |
| Interaction | KCNA3 interactions | CDC42BPA SLC25A5 TCOF1 ATG2B RNF213 PTPN23 FYCO1 NUP214 RSRC2 PABPC1 ATP6V1H AIFM1 AHNAK TLN1 AHCY PAK2 ROBO1 MACF1 TLN2 BOD1L1 ALDH3A2 | 1.02e-05 | 871 | 166 | 21 | int:KCNA3 |
| Interaction | PRTN3 interactions | 1.03e-05 | 91 | 166 | 7 | int:PRTN3 | |
| Interaction | HDAC1 interactions | RAPGEF6 CDC42BPA EP400 SLC25A5 SLC25A6 NSD2 ATG2B KPNA6 SPAG9 NUP214 BIRC6 TUBA1B GSE1 BRCA2 AIFM1 GLI2 AHNAK TLN1 TNRC6A MBD2 PHF21B MRTFA PGBD3 NPAT | 1.36e-05 | 1108 | 166 | 24 | int:HDAC1 |
| Interaction | ZC2HC1A interactions | 1.44e-05 | 64 | 166 | 6 | int:ZC2HC1A | |
| Interaction | BSG interactions | SLC25A5 SLC25A6 TUBA3D TUBA1C RNF213 TUBA3E GPRIN3 PRPF6 PFKP TUBA8 TUBA4A TUBA3C ELAC2 TUBA1B TUBA1A ATP4A AHNAK2 | 1.89e-05 | 631 | 166 | 17 | int:BSG |
| Interaction | PAK1 interactions | SLC25A4 SLC25A5 SLC25A6 TUBA1C TUBA3E TUBA3C TUBA1B TUBA1A AIFM1 PAK2 | 2.09e-05 | 229 | 166 | 10 | int:PAK1 |
| Interaction | NUP210P1 interactions | 2.37e-05 | 42 | 166 | 5 | int:NUP210P1 | |
| Interaction | MKNK1 interactions | 2.42e-05 | 70 | 166 | 6 | int:MKNK1 | |
| Interaction | LOC254896 interactions | 2.67e-05 | 43 | 166 | 5 | int:LOC254896 | |
| Interaction | AGR2 interactions | ACAA1 SLC25A5 SLC25A6 TUBA3D TUBA1C GPRIN3 FYCO1 PFKP ZZEF1 PABPC1 TXNRD1 UBE2V1 AIFM1 AHNAK TLN1 AHCY MACF1 RBM46 ATP4A AHNAK2 TPI1 | 2.88e-05 | 934 | 166 | 21 | int:AGR2 |
| Interaction | LRP1 interactions | DDX12P FMR1 SLC25A5 SLC25A6 TUBA1C ADGRV1 LRP1B TUBA4A TUBA1A | 3.69e-05 | 196 | 166 | 9 | int:LRP1 |
| Interaction | ITGAD interactions | 3.72e-05 | 46 | 166 | 5 | int:ITGAD | |
| Interaction | GABRA1 interactions | 3.84e-05 | 152 | 166 | 8 | int:GABRA1 | |
| Interaction | SIRT7 interactions | NES ZSWIM8 FMR1 TCOF1 NSD2 TUBA1C SPAG9 PRPF6 NUP214 PFKP BIRC6 PABPC1 UBE2O ANAPC1 AHNAK TLN1 MACF1 RRP7A | 4.38e-05 | 744 | 166 | 18 | int:SIRT7 |
| Interaction | CD81 interactions | TUBA3D TUBA1C TUBA3E SIRPA PFKP TUBA8 PABPC1 TUBA4A TUBA3C TUBA1B TUBA1A | 4.43e-05 | 303 | 166 | 11 | int:CD81 |
| Interaction | GAN interactions | SLC25A4 SLC25A5 SLC25A6 RNF213 TUBA8 ZZEF1 PABPC1 TUBA1B TUBA1A DNAH6 | 4.87e-05 | 253 | 166 | 10 | int:GAN |
| Interaction | BRINP3 interactions | 4.91e-05 | 25 | 166 | 4 | int:BRINP3 | |
| Interaction | ATOH1 interactions | 5.18e-05 | 80 | 166 | 6 | int:ATOH1 | |
| Interaction | B4GALT2 interactions | 5.86e-05 | 119 | 166 | 7 | int:B4GALT2 | |
| Interaction | KLK12 interactions | 6.31e-05 | 10 | 166 | 3 | int:KLK12 | |
| Interaction | IFNE interactions | 6.72e-05 | 27 | 166 | 4 | int:IFNE | |
| Interaction | TXNIP interactions | ZSWIM8 SLC25A6 TUBA1C ZCCHC2 TXNRD1 UBE2O MAGED4 TUBA1A AHNAK | 6.77e-05 | 212 | 166 | 9 | int:TXNIP |
| Interaction | GLMP interactions | 6.82e-05 | 84 | 166 | 6 | int:GLMP | |
| Interaction | TXNDC9 interactions | 7.61e-05 | 124 | 166 | 7 | int:TXNDC9 | |
| Interaction | BRD7 interactions | FMR1 SLC25A4 SLC25A5 SLC25A6 TUBA1C RGPD1 PFKP PABPC1 TUBA4A UBE2O TUBA1A AIFM1 ARID2 NEMF ALDH3A2 HNRNPCL2 | 7.69e-05 | 637 | 166 | 16 | int:BRD7 |
| Interaction | XCL1 interactions | 7.79e-05 | 28 | 166 | 4 | int:XCL1 | |
| Interaction | LTA interactions | 7.79e-05 | 28 | 166 | 4 | int:LTA | |
| Interaction | C9orf72 interactions | DDX12P SLC25A4 SLC25A5 SLC25A6 TUBA1C RGPD1 KPNA6 PRPF6 PFKP BIRC6 PABPC1 TUBA4A TUBA3C ELAC2 TUBA1B ATP6V1H MAGED4 TUBA1A ANAPC1 AIFM1 PANK4 AHCY ALDH3A2 OGA TPI1 | 8.03e-05 | 1319 | 166 | 25 | int:C9orf72 |
| Interaction | ARRDC2 interactions | 8.15e-05 | 54 | 166 | 5 | int:ARRDC2 | |
| Interaction | SERPINB11 interactions | 8.63e-05 | 11 | 166 | 3 | int:SERPINB11 | |
| Interaction | MGARP interactions | SLC25A4 SLC25A6 TCP11L1 TUBA1C RNF213 TUBA4A SIL1 ATP6V1H TUBA1A | 9.64e-05 | 222 | 166 | 9 | int:MGARP |
| Interaction | CRYL1 interactions | 9.71e-05 | 56 | 166 | 5 | int:CRYL1 | |
| Interaction | GSK3B interactions | RAPGEF6 FMR1 SLC25A5 KIAA0586 ATG2B RGPD1 BPIFB1 PABPC1 UFM1 TXNRD1 TUBA1B UBE2O TUBA1A TNRC6A PAK2 ROBO1 MACF1 OGA MRTFA | 1.01e-04 | 868 | 166 | 19 | int:GSK3B |
| Interaction | SOX2 interactions | DDAH2 CDC42BPA EP400 SLC25A5 SLC25A6 ACAT2 NUP214 PFKP TUBA4A TUBA1B ATP6V1H GSE1 TUBA1A UBE2V1 ANAPC1 AIFM1 ARID2 AHCY TNRC6A GPC4 PAK2 MACF1 C4A BOD1L1 MBD2 TPI1 | 1.02e-04 | 1422 | 166 | 26 | int:SOX2 |
| Interaction | PHLPP1 interactions | NES RAPGEF6 TCOF1 ATG2B NUP214 TUBA4A TUBA1A AHNAK TLN1 ROBO1 AHNAK2 | 1.03e-04 | 333 | 166 | 11 | int:PHLPP1 |
| Interaction | SERBP1 interactions | FMR1 CDC42BPA SLC25A5 TCOF1 SLC25A6 ACAT2 TUBA1C NUTM2A TUBA3E SPAG9 NFS1 PABPC1 TUBA4A TUBA3C TUBA1B SCAF1 UBE2O ATP6V1H NUTM2B TUBA1A AIFM1 TLN1 NEMF AHCY TNRC6A TPI1 | 1.15e-04 | 1432 | 166 | 26 | int:SERBP1 |
| Interaction | NXPH3 interactions | 1.15e-04 | 58 | 166 | 5 | int:NXPH3 | |
| Interaction | GML interactions | 1.15e-04 | 58 | 166 | 5 | int:GML | |
| Interaction | LYPD1 interactions | 1.15e-04 | 58 | 166 | 5 | int:LYPD1 | |
| Interaction | VAV1 interactions | SLC25A5 SLC25A6 TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A GLI2 MERTK | 1.18e-04 | 228 | 166 | 9 | int:VAV1 |
| Interaction | KLHL40 interactions | 1.25e-04 | 59 | 166 | 5 | int:KLHL40 | |
| Interaction | PHF21A interactions | RAPGEF6 ATG2B NUP214 BIRC6 GSE1 BRCA2 ANAPC1 AHNAK TNRC6A MRTFA NPAT | 1.33e-04 | 343 | 166 | 11 | int:PHF21A |
| Interaction | ITLN1 interactions | 1.46e-04 | 61 | 166 | 5 | int:ITLN1 | |
| Interaction | UBL4A interactions | SLC25A4 SLC25A5 SLC25A6 TUBA3D TUBA1C TUBA3E TUBA8 PABPC1 TUBA3C TUBA1B TUBA1A | 1.55e-04 | 349 | 166 | 11 | int:UBL4A |
| Interaction | DUSP16 interactions | 1.58e-04 | 237 | 166 | 9 | int:DUSP16 | |
| Interaction | RNF123 interactions | SLC25A5 TOPAZ1 RNF213 SPAG9 PFKP ZZEF1 BIRC6 ELAC2 FOCAD SCAF1 CDH20 GSE1 TUBA1A AIFM1 AHNAK ZNF408 TLN1 BOD1L1 | 1.59e-04 | 824 | 166 | 18 | int:RNF123 |
| Interaction | AQP3 interactions | SLC25A4 SLC25A6 TUBA1C TUBA4A SLC7A2 ATP6V1H TUBA1A ICAM5 PANK4 | 1.68e-04 | 239 | 166 | 9 | int:AQP3 |
| Interaction | LIPC interactions | 1.70e-04 | 34 | 166 | 4 | int:LIPC | |
| Interaction | LRRN4CL interactions | 1.84e-04 | 64 | 166 | 5 | int:LRRN4CL | |
| Interaction | MAP1LC3B interactions | TCOF1 SLC25A6 ABHD10 KPNA6 FYCO1 SPAG9 PFKP BIRC6 TUBA4A TUBA1B SYNGR2 AHCY YIPF3 MRTFA | 1.94e-04 | 551 | 166 | 14 | int:MAP1LC3B |
| Interaction | TTC5 interactions | 1.98e-04 | 65 | 166 | 5 | int:TTC5 | |
| Interaction | NUP43 interactions | EP400 NSD2 PRPF6 NUP214 SCAF1 GSE1 BRCA2 ZNF532 TUBA1A UBE2V1 ARID2 RECQL5 BOD1L1 AHNAK2 NPAT | 2.13e-04 | 625 | 166 | 15 | int:NUP43 |
| Interaction | KLK11 interactions | 2.13e-04 | 36 | 166 | 4 | int:KLK11 | |
| Interaction | FPR1 interactions | 2.20e-04 | 147 | 166 | 7 | int:FPR1 | |
| Interaction | SMC5 interactions | EP400 SLC25A4 SLC25A5 NSD2 TUBA1C NUTM2A PRPF6 NUP214 FANCM PABPC1 TUBA4A TUBA1B BRCA2 NUTM2B ARID2 AHNAK RECQL5 BOD1L1 HNRNPCL2 NPAT | 2.20e-04 | 1000 | 166 | 20 | int:SMC5 |
| Interaction | AIFM1 interactions | SLC25A5 TUBA1C TUBA3E ACOT1 ARMCX4 NFS1 TUBA4A ELAC2 UBE2O ATP6V1H TUBA1A AIFM1 PANK4 ALDH3A2 TPI1 | 2.28e-04 | 629 | 166 | 15 | int:AIFM1 |
| Interaction | TNPO1 interactions | TUBA1C KPNA6 NUP214 PFKP TUBA4A TXNRD1 TUBA1B UBE2O TUBA1A TNRC6A | 2.32e-04 | 306 | 166 | 10 | int:TNPO1 |
| Interaction | RCOR1 interactions | RAPGEF6 ATG2B SPAG9 BIRC6 TUBA1B GSE1 BRCA2 ANAPC1 AHNAK MBD2 PHF21B MRTFA NPAT | 2.36e-04 | 494 | 166 | 13 | int:RCOR1 |
| Interaction | TSPYL6 interactions | 2.45e-04 | 68 | 166 | 5 | int:TSPYL6 | |
| Interaction | CDHR4 interactions | 2.45e-04 | 68 | 166 | 5 | int:CDHR4 | |
| Interaction | CTDSP1 interactions | 2.60e-04 | 107 | 166 | 6 | int:CTDSP1 | |
| Interaction | SNRNP40 interactions | EP400 TCOF1 NSD2 KPNA6 PRPF6 TUBA1B DUS2 SCAF1 GSE1 BRCA2 ZNF532 ARID2 ZNF451 RECQL5 NPAT | 2.61e-04 | 637 | 166 | 15 | int:SNRNP40 |
| Interaction | DCAF12 interactions | 2.73e-04 | 108 | 166 | 6 | int:DCAF12 | |
| Interaction | KDM1A interactions | RAPGEF6 FMR1 EP400 NSD2 ATG2B FYCO1 NUP214 BIRC6 GSE1 BRCA2 ZNF532 ANAPC1 AHNAK ZNF451 TNRC6A MBD2 PHF21B MRTFA NPAT | 2.84e-04 | 941 | 166 | 19 | int:KDM1A |
| Interaction | FAM187B interactions | 2.84e-04 | 16 | 166 | 3 | int:FAM187B | |
| Interaction | INSYN2A interactions | 2.92e-04 | 39 | 166 | 4 | int:INSYN2A | |
| Interaction | TULP2 interactions | 2.92e-04 | 39 | 166 | 4 | int:TULP2 | |
| Interaction | KBTBD4 interactions | SLC25A6 KPNA6 PABPC1 TUBA4A AIFM1 AHNAK AHCY TLN2 ATP4A MRTFA | 3.00e-04 | 316 | 166 | 10 | int:KBTBD4 |
| Interaction | SULT1C4 interactions | 3.01e-04 | 110 | 166 | 6 | int:SULT1C4 | |
| Interaction | FBXO42 interactions | EP400 SLC25A4 SLC25A6 ANAPC1 ARID2 RECQL5 TNRC6A MACF1 ALDH3A2 | 3.05e-04 | 259 | 166 | 9 | int:FBXO42 |
| Interaction | HCST interactions | 3.06e-04 | 205 | 166 | 8 | int:HCST | |
| Interaction | FGD5 interactions | 3.26e-04 | 207 | 166 | 8 | int:FGD5 | |
| Interaction | LGR4 interactions | CDC42BPA SLC25A5 TCOF1 PTPN23 TUBA3E TUBA8 TUBA1B ANTXR2 ATP4A | 3.32e-04 | 262 | 166 | 9 | int:LGR4 |
| Interaction | SORT1 interactions | 3.37e-04 | 208 | 166 | 8 | int:SORT1 | |
| Interaction | NEK4 interactions | FRAS1 SLC25A4 SLC25A5 SLC25A6 ATG2B TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A AIFM1 ALPK2 HNRNPCL2 | 3.39e-04 | 582 | 166 | 14 | int:NEK4 |
| Interaction | OPALIN interactions | 3.48e-04 | 209 | 166 | 8 | int:OPALIN | |
| Interaction | MEX3A interactions | FMR1 NSD2 PABPC1 SACS AHNAK TLN1 MACF1 HMGXB3 ALPK2 PLD4 AHNAK2 | 3.52e-04 | 384 | 166 | 11 | int:MEX3A |
| Interaction | GZMH interactions | 3.64e-04 | 74 | 166 | 5 | int:GZMH | |
| Interaction | CRYZ interactions | 3.68e-04 | 160 | 166 | 7 | int:CRYZ | |
| Interaction | ECT2 interactions | NES FMR1 TCOF1 SPAG9 PRPF6 FANCM LYST PABPC1 WDR59 UBE2O TUBA1A AIFM1 AHNAK MACF1 BOD1L1 ALDH3A2 HNRNPCL2 AHNAK2 | 3.89e-04 | 887 | 166 | 18 | int:ECT2 |
| Interaction | F12 interactions | 4.37e-04 | 77 | 166 | 5 | int:F12 | |
| Interaction | TES interactions | TCP11L1 TUBA1C SOWAHC TUBA4A TUBA1B ATP6V1H AIFM1 TLN1 MACF1 OGA | 4.43e-04 | 332 | 166 | 10 | int:TES |
| Interaction | PTH2R interactions | 4.60e-04 | 119 | 166 | 6 | int:PTH2R | |
| Interaction | PINK1 interactions | NES SLC25A5 TUBA1C SPAG9 PABPC1 TUBA1B UBE2O TUBA1A AIFM1 AHNAK TLN1 AHCY C4A AHNAK2 TPI1 | 5.09e-04 | 679 | 166 | 15 | int:PINK1 |
| Interaction | NPTN interactions | SLC25A4 SLC25A5 SLC25A6 TUBA1C RNF213 TUBA4A FOCAD ATP6V1H TUBA1A | 5.11e-04 | 278 | 166 | 9 | int:NPTN |
| Interaction | MAP2K2 interactions | 5.11e-04 | 278 | 166 | 9 | int:MAP2K2 | |
| GeneFamily | Tubulins | 1.78e-12 | 26 | 108 | 8 | 778 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.11e-05 | 161 | 108 | 7 | 593 | |
| GeneFamily | Solute carriers | SLC26A3 SLC25A4 SLC25A5 SLC25A6 FLVCR1 SLC35G6 SLC7A2 SLC35G3 SLC28A1 SLC35G5 | 1.28e-04 | 395 | 108 | 10 | 752 |
| GeneFamily | CD molecules|V-set domain containing|C1-set domain containing|Signal regulatory proteins | 3.49e-04 | 5 | 108 | 2 | 747 | |
| GeneFamily | Fibronectin type III domain containing | 3.98e-04 | 160 | 108 | 6 | 555 | |
| GeneFamily | Immunoglobulin like domain containing | 1.06e-03 | 193 | 108 | 6 | 594 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RAPGEF6 HIVEP2 FMR1 EP400 RNF213 GPRIN3 KPNA6 RSRC2 BIRC6 LYST TUBA4A ANTXR2 SACS TUBA1A ARID2 AHNAK TLN1 NEMF PAK2 MACF1 BOD1L1 MBD2 OGA NPAT | 3.30e-05 | 1492 | 169 | 24 | M40023 |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | NES TPST1 COL6A2 TUBA1C PABPC1 TXNRD1 THBS2 PIEZO2 ZNF532 SACS GLI2 AHNAK VCAN TLN1 TPI1 | 3.75e-05 | 681 | 169 | 15 | M39175 |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_T4 | 4.00e-05 | 97 | 169 | 6 | M1729 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TPST1 HIVEP2 CDC42BPA SPAG9 WDR37 ZZEF1 TXNRD1 THBS2 ATP6V1H GSE1 BRCA2 SACS ZNF451 MACF1 MBD2 MRTFA NPAT | 4.14e-05 | 856 | 169 | 17 | M4500 |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP | 4.71e-05 | 199 | 169 | 8 | M8390 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_T4 | 4.75e-05 | 100 | 169 | 6 | MM1215 | |
| Coexpression | GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 4.88e-05 | 200 | 169 | 8 | M299 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP | 4.88e-05 | 200 | 169 | 8 | M8312 | |
| Coexpression | GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN | 4.88e-05 | 200 | 169 | 8 | M4971 | |
| Coexpression | GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_DN | 4.88e-05 | 200 | 169 | 8 | M6461 | |
| Coexpression | BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES | 4.94e-05 | 259 | 169 | 9 | M40029 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN | 6.65e-05 | 34 | 169 | 4 | M11023 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN | 6.83e-05 | 155 | 169 | 7 | M6675 | |
| Coexpression | ALONSO_METASTASIS_EMT_UP | 7.47e-05 | 35 | 169 | 4 | M8191 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN | 8.36e-05 | 36 | 169 | 4 | MM486 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.43e-08 | 191 | 170 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.05e-08 | 200 | 170 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 8.05e-08 | 200 | 170 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.66e-07 | 174 | 170 | 8 | 9d22a554617a93701d0945de63cc3e7b24322c40 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.35e-07 | 178 | 170 | 8 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-07 | 184 | 170 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-07 | 184 | 170 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-07 | 184 | 170 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-07 | 187 | 170 | 8 | 028e7d6e1211e123879d2f353dc32fae1185dd8e | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.85e-07 | 189 | 170 | 8 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-07 | 190 | 170 | 8 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.71e-07 | 192 | 170 | 8 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.71e-07 | 192 | 170 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-07 | 193 | 170 | 8 | 5a201ee6f132357c9aacfbad3ae56ed9854c25fd | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-DC2|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.34e-07 | 194 | 170 | 8 | a0cfc8c1cdc0722db39170e4417615b6e6b85041 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.34e-07 | 194 | 170 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.34e-07 | 194 | 170 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.34e-07 | 194 | 170 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.67e-07 | 195 | 170 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Kidney-Fibroblasts|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.05e-06 | 200 | 170 | 8 | 2c265ad8314a21bce50ac21b16da2fea125366ea | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.03e-06 | 162 | 170 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|metastatic_Brain / Location, Cell class and cell subclass | 5.43e-06 | 177 | 170 | 7 | 739496fcc4156f4d5e3de9cd21cf3856037f0678 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-06 | 181 | 170 | 7 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-06 | 181 | 170 | 7 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 6.28e-06 | 181 | 170 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-06 | 181 | 170 | 7 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-7|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.51e-06 | 182 | 170 | 7 | af16334fec2c757b03c84cf252d00e92fa81e4cd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.25e-06 | 185 | 170 | 7 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.51e-06 | 186 | 170 | 7 | 74c238759c5d3fd39127ec0060d0c2cb16b326d4 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.51e-06 | 186 | 170 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.78e-06 | 187 | 170 | 7 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.33e-06 | 189 | 170 | 7 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 8.33e-06 | 189 | 170 | 7 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.63e-06 | 190 | 170 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 8.63e-06 | 190 | 170 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.63e-06 | 190 | 170 | 7 | e2fdbfaf08da3274b6bdda615386aa880040a90a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.93e-06 | 191 | 170 | 7 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.93e-06 | 191 | 170 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.93e-06 | 191 | 170 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.93e-06 | 191 | 170 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-06 | 192 | 170 | 7 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-06 | 192 | 170 | 7 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.23e-06 | 192 | 170 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.23e-06 | 192 | 170 | 7 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.23e-06 | 192 | 170 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 9.23e-06 | 192 | 170 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.55e-06 | 193 | 170 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.55e-06 | 193 | 170 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.55e-06 | 193 | 170 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 9.55e-06 | 193 | 170 | 7 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 9.55e-06 | 193 | 170 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class | 9.88e-06 | 194 | 170 | 7 | c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.88e-06 | 194 | 170 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 195 | 170 | 7 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.06e-05 | 196 | 170 | 7 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.06e-05 | 196 | 170 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 197 | 170 | 7 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | COVID-19|World / Condition, Lineage and Cell class | 1.09e-05 | 197 | 170 | 7 | 228f641d79282cc3dc51b95a1f4b0cccfc200735 | |
| ToppCell | (2)_Fibroblasts-(23)_Fibro-4|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.09e-05 | 197 | 170 | 7 | a183919023a4aca90a06be0e5e89c817b38c5574 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.09e-05 | 197 | 170 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | URO-Myeloid-CD16_Mono|URO / Disease, Lineage and Cell Type | 1.09e-05 | 197 | 170 | 7 | 0201ba77419487e75edd5ea07ad7e5cbe87757d4 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-05 | 197 | 170 | 7 | c747d05bb032abf8dad46ff6f4d1951bbe64b3b4 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.13e-05 | 198 | 170 | 7 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 198 | 170 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.13e-05 | 198 | 170 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 1.13e-05 | 198 | 170 | 7 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 198 | 170 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.13e-05 | 198 | 170 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-05 | 198 | 170 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.13e-05 | 198 | 170 | 7 | 9f9dcf23ffb333105263132d87b90095642294cf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-05 | 198 | 170 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.17e-05 | 199 | 170 | 7 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-05 | 200 | 170 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-05 | 200 | 170 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-05 | 200 | 170 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Sepsis-URO-Myeloid-CD16+_Monocyte|URO / Disease, condition lineage and cell class | 1.20e-05 | 200 | 170 | 7 | 82408dac860899510a1f5849d2b0b1692053fb96 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 145 | 170 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.34e-05 | 149 | 170 | 6 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-05 | 161 | 170 | 6 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-05 | 169 | 170 | 6 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-05 | 169 | 170 | 6 | 42c31fe94e34f54dbbb5d8b33cedb55badd6232c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-05 | 169 | 170 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 171 | 170 | 6 | 992df143d76f9e7fb1997a8996f61e941f0f9d4f | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.23e-05 | 172 | 170 | 6 | 584af6537685cb459bf0fc298e6f46872016c116 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 173 | 170 | 6 | 807183fc23478da9451906dacd88de4e73112e0d | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 173 | 170 | 6 | 2e683ec555dc0036875e0f5674dcc5e93ead205d | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 175 | 170 | 6 | 69b59ec58e64644deb7e07f31ef495ef4a6f6276 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 175 | 170 | 6 | 4f7498b5a0ed52c348a5f94bcd41d830ba7954ea | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 5.94e-05 | 176 | 170 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.13e-05 | 177 | 170 | 6 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-05 | 177 | 170 | 6 | 1b077084b78e62ead603f72c9db6ce74a3953f81 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 6.13e-05 | 177 | 170 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-05 | 177 | 170 | 6 | 88403b055eb9fdf96e4695fb6e0d78179e30a1e3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-05 | 177 | 170 | 6 | 8903aeaab61abd81a148ea623038c5114b8a183b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.52e-05 | 179 | 170 | 6 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 181 | 170 | 6 | 48d28eafbb5f4b141deeb0bf020dfca39e7be7a5 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 181 | 170 | 6 | 0a44781cc34535f061812d1370f748b7bbdef17b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.93e-05 | 181 | 170 | 6 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.15e-05 | 182 | 170 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 182 | 170 | 6 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| Drug | Epothilone D | 1.36e-10 | 12 | 169 | 6 | DB01873 | |
| Drug | Epothilone B | 1.36e-10 | 12 | 169 | 6 | DB03010 | |
| Drug | 3-demethylthiocolchicine | 1.39e-08 | 23 | 169 | 6 | CID000084076 | |
| Drug | oxibendazole | 6.31e-08 | 29 | 169 | 6 | CID000004622 | |
| Drug | ddGDP | 6.31e-08 | 29 | 169 | 6 | CID000134739 | |
| Drug | thiocolchicine | 7.84e-08 | 30 | 169 | 6 | CID000017648 | |
| Drug | tropone | 9.66e-08 | 31 | 169 | 6 | CID000010881 | |
| Drug | AC1L3V8I | 9.66e-08 | 31 | 169 | 6 | CID000122777 | |
| Drug | NSC153858 | 1.18e-07 | 32 | 169 | 6 | CID000547450 | |
| Drug | 2-phenyl-4-quinolone | 1.73e-07 | 34 | 169 | 6 | CID000161091 | |
| Drug | bromocolchicine | 3.92e-07 | 21 | 169 | 5 | CID000161518 | |
| Drug | colchifoline | 3.92e-07 | 21 | 169 | 5 | CID000100132 | |
| Drug | Ustiloxin A | 3.92e-07 | 21 | 169 | 5 | CID000164454 | |
| Drug | SRI-3072 | 3.92e-07 | 21 | 169 | 5 | CID000493469 | |
| Drug | Clodronate | 4.02e-07 | 3 | 169 | 3 | DB00720 | |
| Drug | 3,4,5-trimethoxyacetophenone | 5.05e-07 | 22 | 169 | 5 | CID000014345 | |
| Drug | AC1L1GIQ | 5.05e-07 | 22 | 169 | 5 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 5.05e-07 | 22 | 169 | 5 | CID000098538 | |
| Drug | SureCN13401588 | 5.05e-07 | 22 | 169 | 5 | CID009897422 | |
| Drug | N-methyldemecolcine | 5.05e-07 | 22 | 169 | 5 | CID000023759 | |
| Drug | NSC-339672 | 5.05e-07 | 22 | 169 | 5 | CID000433930 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 6.41e-07 | 23 | 169 | 5 | CID000006858 | |
| Drug | AC1L2P05 | 6.41e-07 | 23 | 169 | 5 | CID000125688 | |
| Drug | 2,3,4-tabp | 6.41e-07 | 23 | 169 | 5 | CID000125548 | |
| Drug | NSC-373301 | 6.41e-07 | 23 | 169 | 5 | CID000341375 | |
| Drug | NSC355636 | 6.41e-07 | 23 | 169 | 5 | CID000100176 | |
| Drug | IKP104 | 6.41e-07 | 23 | 169 | 5 | CID000130739 | |
| Drug | fluorescein-colchicine | 6.41e-07 | 23 | 169 | 5 | CID003035871 | |
| Drug | 2,3,4-TCB | 6.41e-07 | 23 | 169 | 5 | CID000129239 | |
| Drug | N-acetylcolchinol | 6.41e-07 | 23 | 169 | 5 | CID000097865 | |
| Drug | Stylophorin | 7.43e-07 | 43 | 169 | 6 | CID000010147 | |
| Drug | parbendazole | 8.05e-07 | 24 | 169 | 5 | CID000026596 | |
| Drug | tropolone methyl ether | 8.05e-07 | 24 | 169 | 5 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 8.05e-07 | 24 | 169 | 5 | CID000330401 | |
| Drug | NABV | 8.05e-07 | 24 | 169 | 5 | CID000175959 | |
| Drug | AC1L4TG7 | 8.05e-07 | 24 | 169 | 5 | CID000163705 | |
| Drug | moscatilin | 8.05e-07 | 24 | 169 | 5 | CID000176096 | |
| Drug | NSC-36768 | 8.05e-07 | 24 | 169 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 8.05e-07 | 24 | 169 | 5 | CID000014995 | |
| Drug | colchicide | 8.05e-07 | 24 | 169 | 5 | CID000120712 | |
| Drug | methyl ether | 9.81e-07 | 45 | 169 | 6 | CID000008254 | |
| Drug | mpMap | 1.00e-06 | 25 | 169 | 5 | CID000100806 | |
| Drug | AC1Q6P06 | 1.00e-06 | 25 | 169 | 5 | CID000160263 | |
| Drug | allocolchicine | 1.00e-06 | 25 | 169 | 5 | CID000196989 | |
| Drug | 1069C85 | 1.00e-06 | 25 | 169 | 5 | CID006918099 | |
| Drug | 55623-37-5 | 1.00e-06 | 25 | 169 | 5 | CID006438440 | |
| Drug | MDL 27048 | 1.00e-06 | 25 | 169 | 5 | CID006439188 | |
| Drug | NBD-colcemid | 1.00e-06 | 25 | 169 | 5 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 1.00e-06 | 25 | 169 | 5 | CID000043264 | |
| Drug | CA1P | 1.00e-06 | 25 | 169 | 5 | CID006918545 | |
| Drug | peloruside A | 1.00e-06 | 25 | 169 | 5 | CID006918506 | |
| Drug | NSC142227 | 1.00e-06 | 25 | 169 | 5 | CID000073427 | |
| Drug | NSC527981 | 1.23e-06 | 26 | 169 | 5 | CID000352796 | |
| Drug | NSC332029 | 1.23e-06 | 26 | 169 | 5 | CID000100073 | |
| Drug | indibulin | 1.23e-06 | 26 | 169 | 5 | CID000002929 | |
| Drug | pironetin | 1.23e-06 | 26 | 169 | 5 | CID006438891 | |
| Drug | isaxonine | 1.23e-06 | 26 | 169 | 5 | CID000071169 | |
| Drug | AC1L1J4H | 1.50e-06 | 27 | 169 | 5 | CID000004862 | |
| Drug | dinitroanilines | 1.50e-06 | 27 | 169 | 5 | CID000136400 | |
| Drug | NSC292222 | 1.50e-06 | 27 | 169 | 5 | CID000099957 | |
| Drug | NSC D-669356 | 1.50e-06 | 27 | 169 | 5 | CID000178028 | |
| Drug | thiabendazole | 1.56e-06 | 76 | 169 | 7 | CID000005430 | |
| Drug | dehydroabietylamine | 1.60e-06 | 4 | 169 | 3 | ctd:C000600819 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 1.60e-06 | 4 | 169 | 3 | DB07574 | |
| Drug | NSC 370147 | 1.82e-06 | 28 | 169 | 5 | CID000182762 | |
| Drug | NSC72302 | 1.82e-06 | 28 | 169 | 5 | CID000118078 | |
| Drug | combretastatin | 2.09e-06 | 51 | 169 | 6 | CID000100154 | |
| Drug | bp U | 2.18e-06 | 29 | 169 | 5 | CID000368697 | |
| Drug | Aids106696 | 2.18e-06 | 29 | 169 | 5 | CID006475933 | |
| Drug | AC1NBBHE | 2.60e-06 | 30 | 169 | 5 | CID004490620 | |
| Drug | eleutherobin | 2.60e-06 | 30 | 169 | 5 | CID006918335 | |
| Drug | azatoxin | 2.60e-06 | 30 | 169 | 5 | CID000125383 | |
| Drug | NSC617668 | 2.60e-06 | 30 | 169 | 5 | CID000357989 | |
| Drug | citostal | 2.60e-06 | 30 | 169 | 5 | CID000018991 | |
| Drug | NSC 89199 | 2.94e-06 | 54 | 169 | 6 | CID000003268 | |
| Drug | S)-monastrol | 2.94e-06 | 54 | 169 | 6 | CID000794323 | |
| Drug | NSC609395 | 3.09e-06 | 31 | 169 | 5 | CID005488798 | |
| Drug | amiprophosmethyl | 3.09e-06 | 31 | 169 | 5 | CID000100524 | |
| Drug | AC7700 | 3.09e-06 | 31 | 169 | 5 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 3.09e-06 | 31 | 169 | 5 | CID000032851 | |
| Drug | NSC332598 | 3.09e-06 | 31 | 169 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 3.09e-06 | 31 | 169 | 5 | CID000023678 | |
| Drug | AC1L1G95 | 3.64e-06 | 32 | 169 | 5 | CID000003583 | |
| Drug | E2-3,4-Q | 3.64e-06 | 32 | 169 | 5 | CID000067402 | |
| Drug | 2-demethylcolchicine | 3.64e-06 | 32 | 169 | 5 | CID000023757 | |
| Drug | 2,5-hexanedione | 3.65e-06 | 56 | 169 | 6 | CID000008035 | |
| Drug | mebendazole | 4.26e-06 | 33 | 169 | 5 | CID000004030 | |
| Drug | CA4P | 4.26e-06 | 33 | 169 | 5 | CID000370232 | |
| Drug | taltobulin | 4.26e-06 | 33 | 169 | 5 | CID006918637 | |
| Drug | triethyllead | 4.96e-06 | 34 | 169 | 5 | CID006328106 | |
| Drug | NSC376450 | 4.96e-06 | 34 | 169 | 5 | CID000005605 | |
| Drug | discodermolide | 5.76e-06 | 35 | 169 | 5 | CID000643668 | |
| Drug | benzimidazole | 6.07e-06 | 93 | 169 | 7 | CID000005798 | |
| Drug | AC1O5Y0F | 7.64e-06 | 37 | 169 | 5 | CID006442852 | |
| Drug | DTAF | 7.64e-06 | 37 | 169 | 5 | CID000123934 | |
| Drug | albendazole | 7.64e-06 | 37 | 169 | 5 | CID000002082 | |
| Drug | baccatin III | 7.64e-06 | 37 | 169 | 5 | CID000065366 | |
| Drug | Michler's ketone | 7.90e-06 | 6 | 169 | 3 | CID000007031 | |
| Drug | tetrahydrouridine | 8.74e-06 | 38 | 169 | 5 | CID000029243 | |
| Drug | gnoscopine | 8.74e-06 | 38 | 169 | 5 | CID000004544 | |
| Disease | microlissencephaly (implicated_via_orthology) | 7.66e-19 | 8 | 164 | 8 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 7.66e-19 | 8 | 164 | 8 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 7.66e-19 | 8 | 164 | 8 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 1.56e-12 | 27 | 164 | 8 | DOID:0050453 (implicated_via_orthology) | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 6.72e-07 | 4 | 164 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | level of tyrosine-protein phosphatase non-receptor type substrate 1 in blood serum | 3.07e-05 | 2 | 164 | 2 | OBA_2040362 | |
| Disease | Disorder of eye | 1.92e-04 | 212 | 164 | 7 | C0015397 | |
| Disease | Retinitis Pigmentosa | 2.94e-04 | 104 | 164 | 5 | C0035334 | |
| Disease | Endometrial Stromal Sarcoma | 3.04e-04 | 5 | 164 | 2 | C0206630 | |
| Disease | Moyamoya disease (is_implicated_in) | 3.04e-04 | 5 | 164 | 2 | DOID:13099 (is_implicated_in) | |
| Disease | Post-Traumatic Osteoporosis | 3.75e-04 | 61 | 164 | 4 | C0751406 | |
| Disease | Osteoporosis, Senile | 3.75e-04 | 61 | 164 | 4 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 3.75e-04 | 61 | 164 | 4 | C0001787 | |
| Disease | Osteoporosis | 4.24e-04 | 63 | 164 | 4 | C0029456 | |
| Disease | Clear cell sarcoma of kidney | 4.54e-04 | 6 | 164 | 2 | C0334488 | |
| Disease | WILMS TUMOR 1 | 4.54e-04 | 6 | 164 | 2 | 194070 | |
| Disease | Wilms tumor 1 | 4.54e-04 | 6 | 164 | 2 | cv:CN033288 | |
| Disease | immature platelet measurement | 5.47e-04 | 119 | 164 | 5 | EFO_0803541 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 5.54e-04 | 29 | 164 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | ductal carcinoma in situ (is_implicated_in) | 6.33e-04 | 7 | 164 | 2 | DOID:0060074 (is_implicated_in) | |
| Disease | Pituitary stalk interruption syndrome | 6.33e-04 | 7 | 164 | 2 | C4053775 | |
| Disease | Nephroblastoma | 8.41e-04 | 8 | 164 | 2 | cv:C0027708 | |
| Disease | Hereditary Wilms tumor | 8.41e-04 | 8 | 164 | 2 | cv:C0677779 | |
| Disease | Kidney Wilms tumor | 8.41e-04 | 8 | 164 | 2 | cv:CN305775 | |
| Disease | melanoma (is_implicated_in) | 8.89e-04 | 34 | 164 | 3 | DOID:1909 (is_implicated_in) | |
| Disease | Intellectual Disability | 9.30e-04 | 447 | 164 | 9 | C3714756 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 9.68e-04 | 35 | 164 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | FAT3 RGPD1 ADAMTS8 ELAC2 TUBA1B VCAN TNRC6A ROBO1 MACF1 IGSF9 | 1.06e-03 | 550 | 164 | 10 | EFO_0004346, EFO_0004464 |
| Disease | intermittent Staphylococcus aureus carrier status | 1.08e-03 | 9 | 164 | 2 | EFO_0007758 | |
| Disease | signal-regulatory protein beta-1 measurement | 1.08e-03 | 9 | 164 | 2 | EFO_0802069 | |
| Disease | platelet component distribution width | HIVEP2 TCP11L1 TUBA1C SIRPB1 SIRPA ZZEF1 TUBA4A UBE2O GSE1 TLN1 PAK2 MACF1 | 1.10e-03 | 755 | 164 | 12 | EFO_0007984 |
| Disease | mitochondrial complex I deficiency (implicated_via_orthology) | 1.34e-03 | 10 | 164 | 2 | DOID:0060536 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 1.43e-03 | 40 | 164 | 3 | C0598589 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.63e-03 | 11 | 164 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement | RAPGEF6 RNF213 GPRIN3 FYCO1 NUP214 BIRC6 CDH20 HMCN2 ROBO1 NINJ1 HMGXB3 MERTK ALPK2 | 1.68e-03 | 904 | 164 | 13 | EFO_0004736 |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.89e-03 | 157 | 164 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.22e-03 | 163 | 164 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Short Rib-Polydactyly Syndrome | 2.30e-03 | 13 | 164 | 2 | C0036996 | |
| Disease | lobe size | 2.67e-03 | 14 | 164 | 2 | EFO_0007666 | |
| Disease | Saldino-Noonan Syndrome | 2.67e-03 | 14 | 164 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 2.67e-03 | 14 | 164 | 2 | C0024507 | |
| Disease | Alobar Holoprosencephaly | 3.07e-03 | 15 | 164 | 2 | C0431363 | |
| Disease | diastolic blood pressure, body mass index | 3.50e-03 | 16 | 164 | 2 | EFO_0004340, EFO_0006336 | |
| Disease | Diabetic Angiopathies | 3.50e-03 | 16 | 164 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 3.50e-03 | 16 | 164 | 2 | C0025945 | |
| Disease | Lobar Holoprosencephaly | 3.50e-03 | 16 | 164 | 2 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 3.50e-03 | 16 | 164 | 2 | C0751617 | |
| Disease | optic cup area measurement | 3.77e-03 | 56 | 164 | 3 | EFO_0006940 | |
| Disease | Holoprosencephaly | 3.95e-03 | 17 | 164 | 2 | C0079541 | |
| Disease | Polydactyly | 4.19e-03 | 117 | 164 | 4 | C0152427 | |
| Disease | Bone marrow hypocellularity | 4.43e-03 | 18 | 164 | 2 | C1855710 | |
| Disease | corneal hysteresis | 5.46e-03 | 20 | 164 | 2 | EFO_0010066 | |
| Disease | Headache | 5.48e-03 | 64 | 164 | 3 | HP_0002315 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| STDQVIKPVNVGALS | 286 | O60507 | |
| KGITAAVVINGSVAN | 246 | Q86TX2 | |
| TAVAEAILPKGSARV | 1061 | Q96L91 | |
| GIAAAISKTAVAPIE | 16 | P12236 | |
| QTVKGASAVAQVALG | 201 | P46092 | |
| SGAEAANKIITVPVF | 3951 | Q9NR09 | |
| QDVVKAAVAAVLSPE | 286 | Q8TDL5 | |
| NVAKEVGPLVSQTDI | 2306 | P13611 | |
| KATAAVAAPLEAEVA | 351 | Q9BUH8 | |
| SLPTVGVFAKATAQD | 501 | O95831 | |
| VSFAIVQASPKDQGL | 1841 | Q86TB3 | |
| IVTIPAGATNIDVKQ | 706 | Q9UP79 | |
| ASLDVEKPVGVAASL | 926 | Q14687 | |
| VLPVSEKAANSQVGF | 4876 | Q8WXG9 | |
| GVAAAISKTAVAPIE | 16 | P05141 | |
| VPAGADPSTVAKVAI | 1556 | Q68CP9 | |
| APILNKAGETLDVSV | 281 | P58335 | |
| SKARVQTPAVVADSG | 2286 | Q8IYW2 | |
| DATTKLNVGAPDVTL | 5351 | Q09666 | |
| IAAGNAVIIKPSELS | 126 | P51648 | |
| AGEVAKADSGPSIVV | 56 | P52569 | |
| NPNVVSKAGAREDTV | 851 | Q5H9R4 | |
| KPLIVATEATSNVLG | 2041 | Q96BY7 | |
| IVDSASELTAGVPNK | 126 | Q15109 | |
| IDGASIEVTLAKPVN | 296 | Q8TBY0 | |
| SVPVKEDAQLGTVIA | 356 | Q9Y5H5 | |
| GPTADSQDTVAAVLK | 346 | Q8NBR0 | |
| GDVPISSIQATIAKL | 1491 | Q9H3S7 | |
| EAAQKAVNSATGVPT | 621 | P11940 | |
| SATKVLIIDAVQPGN | 766 | O60271 | |
| PSIVLADETNLAVKG | 356 | Q14207 | |
| VAAGLKIAPASQIDS | 1141 | Q9H1A4 | |
| VLKAGSAVNIPSDEG | 101 | Q8WXD9 | |
| TSQQTKIVIEAGAVP | 156 | O60684 | |
| VATAKVLISGPNDAS | 2781 | Q86XX4 | |
| SAQGAELTKPFQAVI | 2891 | Q86XX4 | |
| GKNAQVVVSTDILTP | 2351 | Q9NZR2 | |
| VEPQNVVAAAAAKAK | 301 | Q96JG8 | |
| ASQVAVINLAAEPKV | 76 | B2RXH8 | |
| TDAAQAVGKIPLDVN | 231 | Q9Y697 | |
| IVKEAQAQGDPVASA | 381 | O60524 | |
| SAAVTAEKNSVLPGE | 946 | Q12866 | |
| PVVQEGSAVKKVASA | 241 | Q5H9T9 | |
| AVAGDVVSKVSVVNP | 226 | O75487 | |
| VAGEKNEALVPVNSS | 566 | Q9BQS8 | |
| AIKAAVEVANPGSFI | 121 | Q8NDA2 | |
| VESQAAPAVAVEAKA | 611 | Q9P244 | |
| IDVQAGSLTAKVTAP | 916 | Q2LD37 | |
| ATPGSDIKAVQQVIT | 246 | Q8IYD8 | |
| PAKSLVGQVAATVEN | 796 | Q5H9U9 | |
| ATILASIVDSKPNGV | 1201 | Q12766 | |
| AVPGIKALVQATNAI | 191 | Q6ZQW0 | |
| NPRGSAAKNVAVTVE | 556 | Q9UMF0 | |
| VAEGAIDTQNKPITS | 271 | Q01813 | |
| QGLVEAALVSKISSP | 181 | O96028 | |
| NPQVAKEAGIAAESL | 356 | O96028 | |
| AVAGAPKTALETESQ | 1476 | P48681 | |
| AVTVSVPEGTAAVAA | 911 | O94854 | |
| VTAAAISSAGPVAVE | 1596 | P35658 | |
| KASPLVVAAAAAAAV | 31 | P10070 | |
| DVVPVTVAGKLAASG | 426 | Q96KK3 | |
| ALTKGVAILNTSVAP | 266 | A6NM76 | |
| VVAPAGVTLKEANEI | 186 | P20839 | |
| ASQLKAVVEQGPSFA | 61 | Q92982 | |
| QTAESAPGKVVNLTV | 191 | Q9UMZ3 | |
| LDGVVKRAVASQPDS | 456 | Q9NVE7 | |
| ALSNPAANVSVDVKV | 396 | Q96BZ4 | |
| ITGQVSAAVEKNPAV | 336 | Q9UBB5 | |
| ALNAKGTEAPAVVTE | 156 | Q13177 | |
| DSTVAKEGTNVPLVA | 1831 | Q8NFC6 | |
| PSIVAVRNAIDKSVG | 781 | Q9C0G6 | |
| VLVASSVVAGESQKP | 376 | Q06787 | |
| ILAVKQAISGTSPVA | 481 | P51587 | |
| ISGVSKVPIAQDELA | 536 | O14523 | |
| ASEVASGQKIAVPAT | 436 | Q8N960 | |
| GSVPVTIKVLDVNDN | 476 | Q9HBT6 | |
| VIITAPVSAKVADGD | 406 | Q4KMG0 | |
| KQNVVPTVLALGSDV | 966 | P12110 | |
| QKEVVQGSSAPAALF | 511 | Q8N1P7 | |
| EKPLQVASATVSAGL | 1101 | Q8N1P7 | |
| PGTQVLAVFATSKDI | 3251 | Q8TDW7 | |
| VEVKATFGPAIAAVQ | 901 | Q92771 | |
| NIGITNVDVKAIPAD | 521 | Q9Y5Y0 | |
| LSAQVSVSDVPKGVL | 2181 | Q99698 | |
| KAIADTLSIPVIANG | 201 | Q9NX74 | |
| NKDFVVVSIPAAGVL | 141 | Q8N9H9 | |
| PRTVVAGSSDAAQKA | 181 | O95865 | |
| KLNVTAAAAQVGLTP | 646 | Q6ZVF9 | |
| EAAKSPNGLVVVSIF | 171 | Q9NS85 | |
| GILKVPAINVNDSVT | 171 | P23526 | |
| IAKVPGNVDAAVQLT | 601 | Q9NZJ4 | |
| ALAALVPGVTQVDNK | 26 | Q9H7H0 | |
| IASLASGVENEKTPI | 281 | P20648 | |
| VVPTAAAAVSLKVVA | 901 | P0C0L4 | |
| AVSDVPSLSVGKEVQ | 566 | Q5VW36 | |
| KLAAVAQGLQETSIP | 1731 | P0DJD0 | |
| KADLTVQPVAGRVTA | 116 | Q8N328 | |
| VGPVKAAQAQTLVLT | 211 | Q8IVF1 | |
| VGPVKAAQAQTLVLT | 211 | A6NNL0 | |
| VGPVKAAQAQTLVLT | 211 | B1AL46 | |
| AAAEPVTVVAAVGPK | 6 | Q96C34 | |
| ETVLKGQIQAVASPD | 421 | Q9NUJ3 | |
| AVQVVPAGNAATVRK | 121 | Q96KT7 | |
| ALQAKALAETGIAVP | 301 | Q7L4I2 | |
| AVQVVPAGNAATVRK | 121 | Q8N808 | |
| SKEDGQSIVAVVNPA | 411 | Q96GJ1 | |
| DAAVPTNIIAAKAAE | 11 | Q9UI12 | |
| PVALQKAGLTVSDVD | 326 | P09110 | |
| QALAVPESTGALEKT | 1296 | Q8TEU7 | |
| TASAKVAPVRVGTQA | 651 | Q13428 | |
| ISAPGKVVTAAAQAK | 806 | Q13428 | |
| SVPSVGKAVATAAQA | 846 | Q13428 | |
| ASPKELQGVNVIDAV | 341 | Q86VH5 | |
| GAKASVVDGTPLVAA | 406 | O60502 | |
| RLQPGDTAKAVVAQA | 351 | O94906 | |
| AEQTVAKAQTVGLPV | 361 | Q9H0K1 | |
| GAAFSSNPKVQVEAI | 251 | Q9H173 | |
| VIQPDKSVLVAAGET | 36 | P78324 | |
| VSAADKVDAGLPTAI | 146 | Q8N3P4 | |
| KVDAGLPTAIAVSSL | 151 | Q8N3P4 | |
| NAVATVRVDPADGAK | 61 | Q53LP3 | |
| LITPVLKQGADTVSA | 741 | P14410 | |
| VSGAVSKAVPDRNAT | 141 | P40879 | |
| GKASQPSVVISQVID | 1121 | Q5VT25 | |
| LAPAEVVVATVASSG | 426 | Q969V6 | |
| QAVARASTKVEAVPG | 351 | P0CW24 | |
| IQPDKSISVAAGESA | 36 | Q5TFQ8 | |
| PEKVVALIGVATAAD | 166 | Q9NUJ1 | |
| LSIQPLSADVKVQAG | 2201 | Q8IVF2 | |
| GVAAAVSKTAVAPIE | 16 | P12235 | |
| AVVVTAVVAPKAGRE | 6 | A0A1B0GVM6 | |
| VVFQKPSGVSAALAL | 121 | Q9Y3A4 | |
| TNVKVVLPAAGLSAA | 896 | Q9C0B9 | |
| SAPGVSLKEAANVVV | 906 | O94762 | |
| IQPEKSVSVAAGESA | 36 | O00241 | |
| GKAVAAAAPTELQTK | 6 | Q16881 | |
| AVDAVAEPANAVKGA | 271 | Q63HN8 | |
| GDVVPKDVNAAIATI | 321 | P0DPH8 | |
| AAVTFVPVSKVSGQA | 161 | Q96I15 | |
| SITVTGPNVKAVATA | 156 | P62380 | |
| AGPVAVAEKSITQVA | 341 | Q9Y4E5 | |
| AFLPVSAVKTAGSQV | 451 | Q9HCE3 | |
| VGTAAIAPIIAAVKD | 266 | Q9BQ52 | |
| LVSALQAPDGAKVAS | 1181 | Q99973 | |
| LSDKQALGTITAVPV | 36 | Q96EK2 | |
| AAVPVQDLGSTVIKE | 26 | Q9BWD1 | |
| KVSVEVVTAGGAALP | 366 | Q9H7N4 | |
| VAAAKASVPTIQDQA | 1001 | Q9Y490 | |
| RGVAALTSDPAVQAI | 1136 | Q9Y490 | |
| TQPGLDKEAAVAVVT | 181 | Q9H9D4 | |
| GDVVPKDVNAAIATI | 321 | P0DPH7 | |
| IKSVAGVINQPLDVS | 2426 | Q9H5I5 | |
| PSVGQVARVDVSSKV | 676 | Q9C0C9 | |
| SNGVVDPRAISVLAK | 96 | Q13404 | |
| GKELSDQATASPIVA | 86 | Q5JSH3 | |
| IGTLNAAKVPADTEV | 26 | P60174 | |
| VGKAEASATLTVQEP | 336 | Q9Y6N7 | |
| AVTNPKDVLVGADSV | 131 | O43760 | |
| VTNVSVVALPKGANV | 511 | Q9P2J2 | |
| AVQVVPAGNAATVRK | 121 | P0C7Q6 | |
| TGAAISVKVVANIAA | 416 | O00337 | |
| KVPAATSAIITNDGI | 41 | P61960 | |
| PTVALSAVAGASQVK | 141 | Q6PJI9 | |
| VSEPGNIVSNKEVAS | 786 | Q8N9V7 | |
| AAAAVTAAATVVPVI | 1471 | A7E2V4 | |
| DVSVAKTQPVVLGTA | 161 | Q9Y2I8 | |
| LPTTVLNATAKAVAV | 331 | Q9GZM5 | |
| QAPKTDIVAGSTIDQ | 1321 | O43149 | |
| AVSDLLKAVQPTSGE | 621 | Q9Y4G6 | |
| GDVVPKDVNAAIATI | 321 | Q71U36 | |
| GDVVPKDVNAAIATI | 321 | Q6PEY2 | |
| KELVQTANSDPGIAV | 986 | P35442 | |
| GDVVPKDVNAAIATI | 321 | P68363 | |
| SGKLASPSEVVQQVA | 66 | P31629 | |
| GDVVPKDVNAAIATI | 321 | Q9BQE3 | |
| PVIAANLGSAVKVLN | 156 | Q8NDV7 | |
| AATAAAIATAAPLIK | 166 | Q9BVV6 | |
| GDVVPKDVNVAIAAI | 321 | Q9NY65 | |
| GDVVPKDVNAAIAAI | 321 | P68366 | |
| KTIAEQAVAAGVPVE | 116 | Q02108 | |
| QAVAAGVPVEVIKES | 121 | Q02108 |